Loading, Please Wait...
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Bank of America Merrill Lynch Health Care conference in Las Vegas, NV.
Avedro’s management is scheduled to present on Tuesday, May 14, 2019 at 5:15pm Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at www.avedro.com.
Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform is designed to strengthen, stabilize and reshape the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The Avedro Corneal Remodeling Platform is comprised of Avedro’s KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking.
|Avedro Contact:||Investor Contact:|
|David Iannetta||Greg Chodaczek or Lynn Lewis|